🔗 Permalink

Inventor profile of:

Jeffrey Greve

City:

Berkeley, California

Country:

United States

Published Applications:

Last publication date:

2023-12-14

Top Assignees for applications by Jeffrey Greve

The entities that hold a legal rights for patent applications filed by inventor Greve Jeffrey:

Delinia, Inc. 14 Emeryville, CA United States
ATYR PHARMA, INC. 4 San Diego, CA United States
Kyverna Therapeutics, Inc. 2 Emeryville, CA United States
PANGU BIOPHARMA LIMITED 2 Hong Kong, China
Delinia, Inc. 1 Cambridge, MA United States
PANGU BIOPHARMA LIMITED 1 The Landmark, Hong Kong
Delinia, Inc. 1 Berkeley, CA United States

Recent patent applications by Greve Jeffrey

Jeffrey Greve from Berkeley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-12-14

US20230399375A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASE

#2 | 2023-04-06

US20230104151A1

Human necessities

A METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS

#3 | 2022-06-02

US20220169687A1

Chemistry; metallurgy

METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS

#4 | 2022-05-12

US20220143134A1

Human necessities

Method for treating disease using FOXP3+CD4+ T cells

#5 | 2022-04-14

US20220112260A1

Chemistry; metallurgy

MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

#6 | 2022-04-14

US20220110975A1

Human necessities

METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS

#7 | 2021-10-07

US20210308222A1

Human necessities

IL-2 VARIANTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

#8 | 2021-03-11

US20210070828A1

Chemistry; metallurgy

MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

#9 | 2021-02-18

US20210047382A1

Chemistry; metallurgy

MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

#10 | 2020-04-16

US20200115429A1

Chemistry; metallurgy

Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases

#11 | 2020-01-30

US20200031897A1

Chemistry; metallurgy

Multivalent regulatory T cell modulators

#12 | 2019-12-12

US20190375812A1

Chemistry; metallurgy

MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

#13 | 2019-07-04

US20190202882A1

Chemistry; metallurgy

Nucleic acid encoding human IL-2 variant

#14 | 2019-07-04

US20190202881A1

Chemistry; metallurgy

Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases

#15 | 2019-05-23

US20190153058A1

Chemistry; metallurgy

Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases

#16 | 2018-07-31

US15327813

Chemistry; metallurgy

Modified IL-2 variants that selectively activate regulatory T cells

#17 | 2018-06-14

US20180162919A1

Chemistry; metallurgy

Multivalent regulatory T cell modulators

#18 | 2018-05-10

US20180125941A1

Human necessities

IL-2 variants for the treatment of psoriasis

#19 | 2018-02-08

US20180037624A1

Chemistry; metallurgy

Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases

#20 | 2017-11-16

US20170327555A1

Chemistry; metallurgy

MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

#21 | 2017-07-20

US20170204154A1

Chemistry; metallurgy

MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

#22 | 2017-02-23

US20170051029A1

Chemistry; metallurgy

MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

#23 | 2017-02-09

US20170037102A1

Chemistry; metallurgy

MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

#24 | 2016-12-22

US20160369259A1

Chemistry; metallurgy

Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases

#25 | 2015-06-11

US20150159148A1

Chemistry; metallurgy

PEGylated aspartyl-tRNA synthetase polypeptides

#26 | 2015-04-02

US20150093799A1

Chemistry; metallurgy

Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases

#27 | 2014-10-09

US20140302075A1

Chemistry; metallurgy

Aspartyl-tRNA synthetases

#28 | 2013-12-26

US20130344096A1

Chemistry; metallurgy

Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases

InventorID:

585992 ⎘